Hybrid Manufacturing of Oral Solid Dosage Forms via Overprinting of Injection-Molded Tablet Substrates

11. February 2023

Since 3D printing allows for patient-specific dosage forms, it has become a major focus in pharmaceutical research. However, it is...

Oral lipid-based formulations alter delivery of cannabidiol to different anatomical regions in the brain

6. February 2023

Delivery to the brain is a challenging task due to its protection by the blood-brain barrier (BBB). Lipids and fatty...

Composition-Property Relationships of pH-Responsive Poly[(2-vinylpyridine)-co-(butyl methacrylate)] Copolymers for Reverse Enteric Coatings

5. February 2023

The taste-masking of bitter-tasting active pharmaceutical ingredients is key to ensuring patient compliance when producing oral pharmaceutical formulations. This is...

Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension

4. February 2023

Nicardipine hydrochloride is an anti-hypertensive drug that is used off-label to treat hypertension in children. A previous oral formulation of...

Introducing the application of F-Melt® for manufacturing oral disintegrating tablets (ODTS) of Simvastatin

3. February 2023

See the fifth issue of Fuji Chemical Industries Technical Newsletter. It presents the application of F-Melt® for manufacturing oral disintegrating tablets...

Advancing oral delivery of biologics: Machine learning predicts peptide stability in the gastrointestinal tract

2. February 2023

The oral delivery of peptide therapeutics could facilitate precision treatment of numerous gastrointestinal (GI) and systemic diseases with simple administration...

Application of NMP and Neusilin US2-integrated liquisolid technique in mini-tablets for improving the physical performances and oral bioavailability of liposoluble supercritical fluid extracts

2. February 2023

Frankincense and myrrh are widely used Chinese medicines, showing clinically relevant synergistic therapeutic effects in the treatment of inflammation and...

Paediatric Solid Oral Dosage Forms for Combination Products: Improving In Vitro Swallowability of Minitablets Using Binary Mixtures with Pellets

31. January 2023

There is a growing interest in determining and improving the acceptability of solid oral dosage forms (SODF) in paediatric populations....

Formulation, development and characterization of ibuprofen microemulgel for arthritis

25. January 2023

Objective: Microemulgel is composed of aqueous phase, lipophilic phase, along with surfactant and co-surfactant, a suitable gelling agent is also incorporated....

Tackling the Trends – How Excipient Technologies Enable Oral Solid Innovation

23. January 2023

Did you know that between 2015 and 2019, 70% to 80% of new molecular entities (NMEs) approved by the FDA...

Oral Excipients